<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40416">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580240</url>
  </required_header>
  <id_info>
    <org_study_id>2015KY-127</org_study_id>
    <nct_id>NCT02580240</nct_id>
  </id_info>
  <brief_title>Administration of Hydrocortisone for the Treatment of Septic Shock</brief_title>
  <official_title>Administration of Hydrocortisone for the Treatment of Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Jiangsu Province People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northern Jiangsu Province People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study : 1ï¼‰to determine whether hydrocortisone is effective in the
      treatment of septic shock and 2) to identify the role of timing of low dose hydrocortisone
      administration in septic shock patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>within the first 28 days after the onset of septic shock</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>within the first 90 days after the onset of septic shock</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline (300 mg/d as a continuous infusion for 6d, then tapered off.) Once all vasopressors were discontinued, the normal saline taper protocol was initiated (NS 50 mg every 8 h for two days, then NS 50 mg every 12 h for two days, then NS 50 mg daily for one day, then stopped)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hydrocortisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrocortisone (300 mg/d as a continuous infusion for 6d, then tapered off.) Once all vasopressors were discontinued, the hydrocortisone taper protocol was initiated (HC 50 mg every 8 h for two days, then HC 50 mg every 12 h for two days, then HC 50 mg daily for one day, then stopped)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>Hydrocortisone (300 mg/d as a continuous infusion for 6d, then tapered off.) Once all vasopressors were discontinued, the hydrocortisone taper protocol was initiated (HC 50 mg every 8 h for two days, then HC 50 mg every 12 h for two days, then HC 50 mg daily for one day, then stopped)</description>
    <arm_group_label>hydrocortisone</arm_group_label>
    <other_name>cortisol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>Normal saline (300 mg/d as a continuous infusion for 6d, then tapered off.) Once all vasopressors were discontinued, the normal saline taper protocol was initiated (NS 50 mg every 8 h for two days, then NS 50 mg every 12 h for two days, then NS 50 mg daily for one day, then stopped)</description>
    <arm_group_label>saline</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 18 years old or older;

          2. onset of septic shock within 6 h and

          3. treated with norepinephrine

        Exclusion Criteria:

          1. Systemic corticosteroid therapy within the last 3 months before septic shock;

          2. high-dose steroid therapy;

          3. immunosuppression;

          4. refusal of the attending staff or patient family.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qingquan Lv, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Critical Care Medicine, Northern Jiangsu Province people's hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qingquan Lv, Master</last_name>
    <phone>0086-18051063899</phone>
    <email>bonhomie2014@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaohua Gu, Master</last_name>
    <phone>0086-18051062325</phone>
    <email>njguxiaohua@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northern Jiangsu Province people's hospital</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingquan Lv, Master</last_name>
      <phone>0086-18051063899</phone>
      <email>bonhomie2014@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaohua Gu, Master</last_name>
      <phone>0086-18051062325</phone>
      <email>njguxiaohua@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ruiqiang Zheng, Bachelor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qihong Chen, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haixia Wang, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fengdi Yan, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiangquan Yu, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaoyan Wu, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 19, 2015</lastchanged_date>
  <firstreceived_date>October 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northern Jiangsu Province People's Hospital</investigator_affiliation>
    <investigator_full_name>Qing-quan Lv</investigator_full_name>
    <investigator_title>Ms Lv</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>hydrocortisone</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
